Microneedle Drug Delivery CRO/CDMO
Hours: 8:30 AM–5:30 PMSales: +86 10 8928 7035Business: bd@casmn.com

MICRONEEDLE DEVELOPMENT CAPABILITY

Microneedle Clinical-Stage Development Support

Define stage-appropriate batch, documentation, analytical and quality activities according to the product pathway and target market.
01

Clinical-Stage Development Requirements

Clinical-stage support is planned around the product pathway, target market, available development data and agreed project scope.

02

Prerequisites Before Clinical-Stage Support

The required formulation, process, analytical and quality information is reviewed before batch planning begins.

03

Batch Planning

Batch size, timing, materials, packaging and documentation needs are planned project by project.

04

Analytical and Quality Activities

Analytical and quality activities are selected to support the stage and agreed product requirements; CASMN does not imply automatic completion of all regulatory work.

05

Documentation, Traceability and Supply Requirements

Documentation, traceability, packaging and supply requirements are discussed with the sponsor for the intended project pathway.

06

Project-Specific Deliverables

Deliverables are agreed in the project plan and may include batch support, development documentation and technical records.

Technical Review — Reviewed by: CASMN R&D Team · Last reviewed: August 2026.

Discuss This Capability

Send your target product, payload, development stage and cooperation scope to our business development team.

Start a Project